(ESSITY-B) Essity (publ) - Ratings and Ratios
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0009922164
ESSITY-B: Tissues, Wipes, Diapers, Pads, Sanitizers, Towels
Essity AB (publ) is a global leader in hygiene and health products, operating across Europe, the Americas, Asia, and other international markets. With a rich history dating back to 1849, the company has established itself as a cornerstone in the personal care industry. Essitys business is divided into three core segments: Health & Medical, Consumer Goods, and Professional Hygiene.
The Health & Medical segment focuses on advanced solutions for incontinence, wound care, and skincare. Products like TENA, JOBST, and Cutimed are trusted by healthcare professionals and consumers alike. This segment also incorporates digital innovations, such as sensor technology, to enhance patient care and remote monitoring. Distribution channels include pharmacies, hospitals, and e-commerce platforms, ensuring wide accessibility.
The Consumer Goods segment caters to everyday hygiene needs, offering a broad range of products under brands like Libresse, Lotus, and Tempo. From baby care items to intimate hygiene products, this segment addresses the daily essentials of consumers worldwide. The diversity of products, including eco-friendly options like TOM Organic, reflects Essitys commitment to sustainability and consumer preferences.
The Professional Hygiene segment provides tailored solutions for businesses, healthcare facilities, and public venues under the Tork brand. This includes everything from hand sanitizers to data-driven cleaning systems. By combining high-quality products with technology, Essity helps organizations maintain cleanliness and efficiency, adapting to the evolving needs of the professional hygiene market.
From a financial perspective, Essity AB (publ) boasts a market capitalization of approximately 195 billion SEK, with a P/E ratio of 16.45 and a forward P/E of 14.04. The P/B ratio stands at 2.21, and the P/S ratio is 1.35, indicating a valuation that reflects its stable market position and growth prospects. As a large-cap company with a diversified portfolio, Essity offers a balance of stability and potential for long-term growth.
Investors should consider Essitys strong market position, global reach, and commitment to innovation. While the companys size may result in slower growth
Additional Sources for ESSITY-B Stock
ESSITY-B Stock Overview
Market Cap in USD | 20,339m |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
GiC Sub-Industry | Personal Care Products |
IPO / Inception |
ESSITY-B Stock Ratings
Growth 5y | 33.7% |
Fundamental | 47.1% |
Dividend | 52.7% |
Rel. Strength Industry | 14.7 |
Analysts | - |
Fair Price Momentum | 312.10 SEK |
Fair Price DCF | 341.34 SEK |
ESSITY-B Dividends
Dividend Yield 12m | 5.31% |
Yield on Cost 5y | 6.84% |
Annual Growth 5y | -9.12% |
Payout Consistency | 93.6% |
ESSITY-B Growth Ratios
Growth Correlation 3m | -17.9% |
Growth Correlation 12m | 53.7% |
Growth Correlation 5y | 35.5% |
CAGR 5y | 5.57% |
CAGR/Max DD 5y | 0.20 |
Sharpe Ratio 12m | 1.51 |
Alpha | 23.91 |
Beta | -0.10 |
Volatility | 19.18% |
Current Volume | 1534.4k |
Average Volume 20d | 1494.4k |
As of March 12, 2025, the stock is trading at SEK 306.80 with a total of 1,534,373 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +10.32%, over three months by +2.88% and over the past year by +27.12%.
Partly, yes. Based on ValueRay Fundamental Analyses, Essity (publ) (ST:ESSITY-B) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 47.11 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ESSITY-B as of March 2025 is 312.10. This means that ESSITY-B is currently overvalued and has a potential downside of 1.73%.
Essity (publ) has no consensus analysts rating.
According to ValueRays Forecast Model, ESSITY-B Essity (publ) will be worth about 337.1 in March 2026. The stock is currently trading at 306.80. This means that the stock has a potential upside of +9.87%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 321.6 | 4.8% |
Analysts Target Price | - | - |
ValueRay Target Price | 337.1 | 9.9% |